Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors

Subnormal plasma levels of high-density lipoprotein cholesterol (HDL-C) constitute a major cardiovascular risk factor; raising low HDL-C levels may therefore reduce the residual cardiovascular risk that frequently presents in dyslipidaemic subjects despite statin therapy. Cholesteryl ester transfer...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Chapman, M. John, Le Goff, Wilfried, Guerin, Maryse, Kontush, Anatol
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2010
Témata:
Review
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2806550/
https://ncbi.nlm.nih.gov/pubmed/19825813
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/ehp399
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky